Peptide News Digest

#Obesity-Guidelines

1 story

Regulatory · View digest

Yle: Finland's New Obesity Guidelines Warn Doctors Off Chat-Based GLP-1 Prescribing and Lower the Bar for Surgery

The Finnish Medical Society Duodecim's updated Current Care Guidelines advise against prescribing obesity drugs through quick chat consultations and name semaglutide and tirzepatide as the drugs with the strongest evidence, Yle reported. Bariatric surgery can be considered at a BMI of 35 instead of 40, or 30 to 35 with poorly controlled type 2 diabetes, after about six months of basic treatment and without a required 5% pre-referral weight loss. Kela says more than 100,000 Finns used obesity medication last year.